


LipidEra Therapeutics Revenue
Biotechnology Research • Amsterdam, North Holland, Netherlands • 1-10 Employees
LipidEra Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at LipidEra Therapeutics
Patrick Page
Chief Executive Officer
Company overview
| Headquarters | Amsterdam, North Holland, Netherlands |
| Website | |
| NAICS | 541714 |
| Keywords | Genetic And Severe Hypercholesterolemia |
| Founded | 2024 |
| Employees | 1-10 |
About LipidEra Therapeutics
LipidEra Therapeutics is a seed-stage biotech founded in 2024 and based in Amsterdam. We are developing MI-883, a first-in-class, orally administered small molecule that targets the nuclear receptors CAR and PXR for the treatment of genetic and severe hypercholesterolemia. Connect with us to follow our progress and be part of our story as we embark on advancing new therapies.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
LipidEra Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
LipidEra Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



